Skip to content
10-Q

Quarterly Report

MARIMED INC. MRMD

0001522767-24-000065

← back to feed
Filed
Aug 8, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 7, 2024 380.61M sh
Long Term Debt Q2 2024 · Jun 30, 2024 $79.5M
Short Term Investments Q2 2024 · Jun 30, 2024 $0
Short Term Investments Q2 2024 · Dec 31, 2023 $88K
Cash And Equivalents Q2 2024 · Jun 30, 2024 $10.19M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $14.65M
Current Liabilities Q2 2024 · Jun 30, 2024 $40.66M
Current Liabilities Q2 2024 · Dec 31, 2023 $30.86M
Total Liabilities Q2 2024 · Jun 30, 2024 $120.93M
Total Liabilities Q2 2024 · Dec 31, 2023 $107.21M
Current Assets Q2 2024 · Jun 30, 2024 $53.05M
Current Assets Q2 2024 · Dec 31, 2023 $51.43M
Total Assets Q2 2024 · Jun 30, 2024 $208.53M
Total Assets Q2 2024 · Dec 31, 2023 $196.12M
Shares Diluted Q2 2024 · Jun 30, 2023 361.26M sh
Shares Diluted Q2 2024 · Jun 30, 2023 352.08M sh
Capex Q2 2024 · Jun 30, 2023 $8.79M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$3.22M
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Net Income Q2 2024 · Jun 30, 2023 −$958K
Net Income Q2 2024 · Jun 30, 2023 −$1.6M
Operating Income Q2 2024 · Jun 30, 2023 $3.55M
Operating Income Q2 2024 · Jun 30, 2023 $8.68M
Gross Profit Q2 2024 · Jun 30, 2023 $16.38M
Gross Profit Q2 2024 · Jun 30, 2023 $31.76M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $20.14M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $39.14M
Revenue Q2 2024 · Jun 30, 2023 $36.52M
Revenue Q2 2024 · Jun 30, 2023 $70.9M